Insights

Stay Up to Date on the Latest News and Events from SLW

SLW Life Sciences Webinar Series: Patenting Pharmaceutical Solid Forms Revisited

We revisit the patenting of pharmaceutical solid forms—especially crystalline polymorphs—by integrating scientific, regulatory, and legal considerations. Polymorphs are often a central concern in drug performance, lifecycle management, and Hatch Waxman litigation, and they are valuable IP assets for both innovators and generics.  We discuss drafting strategies and illustrate common pitfalls in claim drafting.  In view […]

Modern Induced Infringement: Evolving Standard Based on Recent Supreme Court Decisions

The U.S. Supreme Court has recently examined the induced infringement standard as it relates to “skinny labeling” of pharmaceuticals, first in Teva Pharmaceuticals USA, Inc. v. GlaxoSmithKline LLC (”GSK”) (2023) and recently in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc (2026).  We will examine these outcomes and explore how these decisions may impact various […]

Precision Functional Claiming: Strategic Use of 35 USC § 112(f) to Protect Biological and Chemical Inventions

Senior Attorney Alexandra Cavazos, Ph.D., presents, “Precision Functional Claiming: Strategic Use of 35 USC § 112(f) to Protect Biological and Chemical Inventions.” Dr. Nicholas P. Lanzatella moderates. In the life sciences and chemical arts, means-plus-function claiming under 35 U.S.C. § 112(f) is a powerful, but often overlooked, tool. This presentation takes a close look at the […]